A Randomised Phase II Trial in Early COVID-19, Assessing Use of Camostat by Blocking SARS-CoV-2 Spike Protein-initiated Membrane Fusion
Dhaliwal et al., NCT04455815
https://c19early.org/dhaliwal.html